Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 2nd article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Professor Seebacher, a leading dermatomycologist, always warned us never to end onychomycosis therapy too early. Here are the reasons: Mycosis does not confer immunity. But, above all, […]
Press Release EUROIMMUN today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOffice 4.0 (ELO 4.0) laboratory management software. The combined system of hardware and software allows for ultrafast automated immunofluorescence image acquisition, pattern recognition and titer estimation as well as modern
The project “automated immunofluorescence microscopy” was initiated in 2005 by EUROIMMUN founder Prof Winfried Stöcker, firstly especially for immunofluorescence tests based on HEp-2 cells for the detection of antinuclear antibodies (ANA). At that time, there was an international consent that ANA immunofluorescence diagnostics had to be modernised and made more efficient and especially more standardised.
INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. INOCHEM becomes the 16th affiliate of the Luebeck, Germany-based company. INOCHEM’s relationship with EUROIMMUN spans more than 14 years, initally as sub-distributor of another
On 18 December 2019, our new EUROIMMUN subsidiary in Japan was officially founded after one year of hard work, intensive planning and structuring. Head of this new subsidiary is Cagla Egretaud, who has been working at EUROIMMUN for 20 years. The idea to jointly establish a new subsidiary in Japan, one of the world’s largest
